ES482155A1 - Un procedimiento para la preparacion de derivados de feneta-nolamina. - Google Patents

Un procedimiento para la preparacion de derivados de feneta-nolamina.

Info

Publication number
ES482155A1
ES482155A1 ES482155A ES482155A ES482155A1 ES 482155 A1 ES482155 A1 ES 482155A1 ES 482155 A ES482155 A ES 482155A ES 482155 A ES482155 A ES 482155A ES 482155 A1 ES482155 A1 ES 482155A1
Authority
ES
Spain
Prior art keywords
epinephrine
preparation
derivatives
phenethanolamines
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES482155A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES482155A1 publication Critical patent/ES482155A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/06—Preparation of carboxylic acid nitriles from N-formylated amino compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)

Abstract

Procedimientos para la preparación de nuevos derivados de fenetanolamina, útiles para controlar el peso de los mamíferos. Se han realizado extensas investigaciones en el campo de los derivados de beta-feniletilamina, como las catecolaminas. Por ejemplo, se ha estudiado mucho la catecolamina natural, epinefrina. La epinefrina es un potente fármaco simpatomimético y un intenso estimulante cardiaco. Sin embargo, el uso de la epinefrina es limitado debido a sus efectos secundarios indeseables entre los que se encuentran temor, ansiedad, temblores, tensión nerviosa, dolores de cabeza con latidos, mayor presión sanguínea, vértigos, dificultades respiratorias y palpitaciones así como debido a su corta duración de acción.
ES482155A 1978-07-03 1979-07-03 Un procedimiento para la preparacion de derivados de feneta-nolamina. Expired ES482155A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92167078A 1978-07-03 1978-07-03

Publications (1)

Publication Number Publication Date
ES482155A1 true ES482155A1 (es) 1980-08-16

Family

ID=25445792

Family Applications (4)

Application Number Title Priority Date Filing Date
ES482156A Expired ES482156A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de nuevos derivados de-fenetanolamina.
ES482155A Expired ES482155A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de derivados de feneta-nolamina.
ES490215A Granted ES490215A0 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina
ES490214A Expired ES8104189A1 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES482156A Expired ES482156A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de nuevos derivados de-fenetanolamina.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES490215A Granted ES490215A0 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina
ES490214A Expired ES8104189A1 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina

Country Status (31)

Country Link
EP (3) EP0006766B1 (es)
JP (2) JPS559097A (es)
KR (1) KR880002310B1 (es)
AR (4) AR229080A1 (es)
AT (2) AT372937B (es)
AU (2) AU523720B2 (es)
BE (2) BE877393A (es)
BG (4) BG31646A3 (es)
CA (2) CA1145767A (es)
CH (2) CH643529A5 (es)
CS (4) CS209815B2 (es)
DD (2) DD144762A5 (es)
DE (2) DE2964604D1 (es)
DK (2) DK160936C (es)
EG (1) EG14238A (es)
ES (4) ES482156A1 (es)
FI (2) FI792081A7 (es)
FR (3) FR2430411A1 (es)
GB (3) GB2028799B (es)
GR (2) GR74524B (es)
HU (2) HU179172B (es)
IE (2) IE48769B1 (es)
IL (2) IL57671A (es)
LU (2) LU81458A1 (es)
NZ (2) NZ190863A (es)
PH (2) PH15275A (es)
PL (4) PL117996B1 (es)
PT (2) PT69843A (es)
RO (4) RO77732A (es)
SU (4) SU965350A3 (es)
ZA (2) ZA793297B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
EP0028105B1 (en) * 1979-10-25 1983-01-19 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
ATE14222T1 (de) * 1979-11-15 1985-07-15 Beecham Group Plc Sekundaere aethanolamine, ihre herstellung und ihre verwendung in pharmazeutischen zusammensetzungen.
EP0040000B1 (en) * 1980-05-08 1983-10-12 Beecham Group Plc Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions
EP0066351B1 (en) * 1981-03-06 1985-06-26 Beecham Group Plc Arylethanol amine derivatives, their preparation and use in pharmaceutical compositions
EP0061907B1 (en) * 1981-03-31 1984-08-01 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
EP0070133B1 (en) * 1981-07-11 1986-05-14 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
EP0089154A3 (en) * 1982-03-12 1984-08-08 Beecham Group Plc Ethanolamine derivatives, their preparation and use in pharmaceutical compositions
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
JPS5980640A (ja) * 1982-09-27 1984-05-10 イーライ・リリー・アンド・カンパニー ２−ヒドロキシ−２−フエニルエチルアミン類の製造方法
IL70813A (en) * 1983-01-31 1987-10-30 Lilly Co Eli Animal feed comprising certain phenethanolamine derivatives and 1-phenyl-2-(1-methyl-3-(4-nitrophenyl)propylamino)ethanol hydrochloride
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
US4602044A (en) * 1983-12-19 1986-07-22 Eli Lilly And Company β-phenethanolamine antiobesity agents
HU191313B (en) * 1984-01-12 1987-02-27 Eli Lilly And Co,Us Process for preparing compounds with inotropic activity
GB8505284D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Growth promoters
PT82120B (en) * 1985-03-01 1988-06-16 Beecham Group Plc Process for preparing veterinary formulations containing ethanolamine derivatives
IT1204416B (it) * 1986-06-27 1989-03-01 Midy Spa Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini
JP2837408B2 (ja) * 1987-05-30 1998-12-16 鐘紡株式会社 アクリル系繊維の処理方法
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
FI892341L (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanolaminderivat.
CA2023954C (en) * 1989-10-17 1999-05-04 Hiroyuki Nohira Process for the optical resolution of 2-(3-benzoyl) phenylpropionic acid
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
ATE313321T1 (de) * 1991-08-23 2006-01-15 Nps Pharma Inc Kalzium-rezeptor aktive verbindungen
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
ES2285707T3 (es) 1994-10-21 2007-11-16 Nps Pharmaceuticals, Inc. Compuestos activos frente al receptor de calcio.
WO1997041090A1 (en) 1996-05-01 1997-11-06 Nps Pharmaceuticals, Inc. Inorganic ion receptor-active compounds
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL56308C (es) * 1941-03-15
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1301134A (en) 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
BE788850A (fr) * 1972-09-15 1973-03-15 Hoffmann La Roche Derives d'acide benzoique
IE39247B1 (en) * 1973-05-07 1978-08-30 Allen & Hanburys Ltd Substituted benzamides
US4000192A (en) * 1973-05-07 1976-12-28 Allen & Hanburys Limited Pharmacologically active compounds
NZ190854A (en) * 1978-06-28 1984-10-19 Beecham Group Ltd 2-hydroxy-2-phenyl ethylamine derivatives;pharmaceutical compositions
DK269079A (da) * 1978-07-03 1980-02-01 Lilly Co Eli Fremgangsmaade til fremstilling af phenethanolaminer

Also Published As

Publication number Publication date
FR2430410A1 (fr) 1980-02-01
ES490214A0 (es) 1981-04-16
AU523721B2 (en) 1982-08-12
LU81457A1 (fr) 1979-10-30
DK268779A (da) 1980-01-04
ES8104190A1 (es) 1981-04-16
FI792082A7 (fi) 1981-01-01
AT372937B (de) 1983-11-25
IE791227L (en) 1980-01-03
CA1142954A (en) 1983-03-15
GR74524B (es) 1984-06-29
NZ190861A (en) 1981-12-15
DE2964091D1 (en) 1982-12-30
PH14522A (en) 1981-08-26
HU179172B (en) 1982-08-28
CH643529A5 (fr) 1984-06-15
DK160936B (da) 1991-05-06
EP0006766B1 (en) 1983-01-26
FR2430410B1 (fr) 1986-03-21
AU523720B2 (en) 1982-08-12
DD144762A5 (de) 1980-11-05
IL57671A0 (en) 1979-10-31
AR231434A1 (es) 1984-11-30
RO77732A (ro) 1981-11-24
ES8104189A1 (es) 1981-04-16
IL57672A (en) 1983-03-31
HU179171B (en) 1982-08-28
AT367025B (de) 1982-05-25
EG14238A (en) 1983-12-31
CH642618A5 (fr) 1984-04-30
RO77728A (ro) 1981-11-24
SU965350A3 (ru) 1982-10-07
KR830001187A (ko) 1983-04-29
RO83052A (ro) 1984-02-21
IL57672A0 (en) 1979-10-31
JPS6254095B2 (es) 1987-11-13
DD144761A5 (de) 1980-11-05
ZA793296B (en) 1981-02-25
BE877394A (fr) 1980-01-02
JPS559097A (en) 1980-01-22
FR2450806B1 (fr) 1985-07-12
FR2430411A1 (fr) 1980-02-01
EP0007204B1 (en) 1982-11-24
GB2028802A (en) 1980-03-12
SU957761A3 (ru) 1982-09-07
GB2028799B (en) 1982-09-08
AU4848779A (en) 1980-01-10
BG31375A3 (bg) 1981-12-15
CS208663B2 (en) 1981-09-15
SU849997A3 (ru) 1981-07-23
RO83052B (ro) 1984-02-28
AR227165A1 (es) 1982-09-30
PL121297B1 (en) 1982-04-30
KR880002310B1 (ko) 1988-10-22
BG31645A3 (bg) 1982-02-15
IE791228L (en) 1980-01-03
AR225744A1 (es) 1982-04-30
NZ190863A (en) 1982-05-25
CS208664B2 (en) 1981-09-15
PH15275A (en) 1982-11-02
ES490215A0 (es) 1981-04-16
GB2101582A (en) 1983-01-19
BE877393A (fr) 1980-01-02
EP0006766A1 (en) 1980-01-09
FR2430411B1 (es) 1983-08-19
IE48769B1 (en) 1985-05-15
PL216811A1 (es) 1980-08-25
LU81458A1 (fr) 1979-10-30
IE48586B1 (en) 1985-03-20
AU4848979A (en) 1980-01-10
GB2101582B (en) 1983-06-08
CS209815B2 (en) 1981-12-31
DK160936C (da) 1991-10-21
ES482156A1 (es) 1980-08-16
RO83051B (ro) 1984-02-28
EP0007204A1 (en) 1980-01-23
PL216814A1 (es) 1980-03-24
SU1007554A3 (ru) 1983-03-23
BG31647A3 (bg) 1982-02-15
PL117551B1 (en) 1981-08-31
ZA793297B (en) 1981-02-25
PT69839A (en) 1979-07-01
RO83051A (ro) 1984-02-21
DE2964604D1 (en) 1983-03-03
DK268679A (da) 1980-01-04
AR229080A1 (es) 1983-06-15
IL57671A (en) 1982-11-30
ATA463579A (de) 1983-04-15
FI792081A7 (fi) 1981-01-01
PL117997B1 (en) 1981-09-30
PL117996B1 (en) 1981-09-30
GB2028799A (en) 1980-03-12
FR2450806A1 (fr) 1980-10-03
EP0048037A1 (en) 1982-03-24
ATA463679A (de) 1981-10-15
JPS559096A (en) 1980-01-22
CA1145767A (en) 1983-05-03
BG31646A3 (bg) 1982-02-15
CS208662B2 (en) 1981-09-15
GR72940B (es) 1984-01-16
PT69843A (en) 1979-07-01
GB2028802B (en) 1983-03-30

Similar Documents

Publication Publication Date Title
ES482155A1 (es) Un procedimiento para la preparacion de derivados de feneta-nolamina.
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES246233Y (es) Aplicador utilizable para el masaje del revestimiento cuta- neo
ES2054716T3 (es) Bis-naftalimidas, su obtencion y empleo.
MX7012A (es) Procedimiento para preparar derivados de acido-cis,endo-2-azabiciclo-(5.3.0.)-decan-3-carboxilico.
ES2194935T3 (es) Preparados estables de transglutaminasa y procedimiento para su preparacion.
ATE77047T1 (de) Sebosuppressive topische zubereitungen.
IT8067134A0 (it) Derivati dell alcool benzilico particolarmente utili come antidiabetici e procedimento per la loro preparazione
ES8800678A1 (es) Un procedimiento para la preparacion de nuevos benzotiofenos
IT1046291B (it) Procedimento per la preparazione di pelli purificate pronte per la concia di pelli animali
IT1065722B (it) Carbammati procedimento per la loro preparazione e loro impiego come agenti disinfestanti e come regolatori della crescita delle piante
ES8100859A1 (es) Un procedimiento para preparar una dispersion espesada acuo-sa y acida, para emplear, bien sea directamente como tal, o-como una base para un producto alimenticio.
ES2061828T3 (es) Composiciones antiirritantes y desensibilizadoras y metodos para su uso.
DK216280A (da) Geometriske isomere af 4,4-dimethyl-1-phenyl-2-(1,2,4-triazol-yl)-1-pentan-3-oler og fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
AR220335A1 (es) Procedimiento para la preparacion de 4(2-hidroxi-3-(amino)-propoxi)-2-benzimidazolinonas y-tionas y compuestos para su exclusivo uso como intermediarios en dicho procedimiento
ES544664A0 (es) Procedimiento para el diagnostico in vitro del sexo
ES8406877A1 (es) Procedimiento de fabricacion de preparaciones cosmeticas extemporaneas.
AR229875A1 (es) Procedimiento para la preparacion de derivados de 4-sulfanoil fenil-3-sustituido-2-fenilimino-4-tiazolina,intermediarios para su uso exclusivo en el procedimiento y procedimiento para obtener preparados farmaceuticos
ES478414A1 (es) Un procedimiento para la preparacion de n-aril-1,3-oxazoli- din-2,4-dionas.
AR225286A1 (es) Nuevas composiciones cosmeticas para combatir el estado grasoso del cabello y de la piel;compuestos de n-(mercapto-2-etil)-beta-hidroxietilamina de aplicacion exclusiva en dichas composiciones y procedimiento para prepararlas
IT1120976B (it) Derivati otticamente attivi della ossazafosforina e procedimento per la loro preparazione
ES556437A0 (es) Procedimiento para preparar un agente que contiene tirosina o un derivado de tirosina como sustancia activa para mejorar la fecundidad de mamiferos.
IT7868891A0 (it) Derivati dell'alcool benzilico eprocedimento per la loro preparazione
ES2059633T3 (es) 2-terc.-butil-4-cloro-5-(4-terc.-butilbenciltio)-3(2h)-piridazinona para la lucha contra los moluscos.
DK356579A (da) Fluorholdige phenyleddikesyreestere fremgangsmaade til deres fremstilling deres anvendelse som insecticider og acaricider og mellemprodukter til deres fremstilling

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010201